CS202594B2 - Process for preparing 7 beta-acylamino-7 alpha-metoxy-3-pyrazinylthiomethyl-3-cephem-4-carboxylates - Google Patents
Process for preparing 7 beta-acylamino-7 alpha-metoxy-3-pyrazinylthiomethyl-3-cephem-4-carboxylates Download PDFInfo
- Publication number
- CS202594B2 CS202594B2 CS781786A CS178678A CS202594B2 CS 202594 B2 CS202594 B2 CS 202594B2 CS 781786 A CS781786 A CS 781786A CS 178678 A CS178678 A CS 178678A CS 202594 B2 CS202594 B2 CS 202594B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- cephem
- pyrazinylthiomethyl
- methoxy
- acylamino
- thienyl
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 5
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- 150000001875 compounds Chemical class 0.000 claims description 8
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- -1 pivaloyloxymethyl Chemical group 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- IXZDIALLLMRYOU-UHFFFAOYSA-N tert-butyl hypochlorite Chemical compound CC(C)(C)OCl IXZDIALLLMRYOU-UHFFFAOYSA-N 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 claims description 2
- 125000005633 phthalidyl group Chemical group 0.000 claims description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 125000005301 thienylmethyl group Chemical group [H]C1=C([H])C([H])=C(S1)C([H])([H])* 0.000 claims description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims 1
- 229910052744 lithium Inorganic materials 0.000 claims 1
- 239000011541 reaction mixture Substances 0.000 claims 1
- BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 claims 1
- 229940124587 cephalosporin Drugs 0.000 abstract description 4
- 108090000204 Dipeptidase 1 Proteins 0.000 abstract description 3
- 102000006635 beta-lactamase Human genes 0.000 abstract description 3
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 2
- 239000000543 intermediate Substances 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 125000003373 pyrazinyl group Chemical group 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 125000001544 thienyl group Chemical group 0.000 description 7
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 6
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Substances CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 5
- 101150041968 CDC13 gene Proteins 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229930186147 Cephalosporin Natural products 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 150000001780 cephalosporins Chemical class 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 241000588697 Enterobacter cloacae Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- JHWOBKLTTLRWML-YYGLIYBVSA-N (6R)-4-acetamido-4-benzhydryl-8-oxo-3-(pyrazin-2-ylsulfanylmethyl)-7-thiophen-2-yl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound CC(=O)NC1(C(=C(N2[C@H](S1)C(C2=O)C3=CC=CS3)C(=O)O)CSC4=NC=CN=C4)C(C5=CC=CC=C5)C6=CC=CC=C6 JHWOBKLTTLRWML-YYGLIYBVSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- FADWHMWTUOKTMV-UHFFFAOYSA-N 6-methoxy-1h-pyrazine-2-thione Chemical compound COC1=CN=CC(S)=N1 FADWHMWTUOKTMV-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- HOKIDJSKDBPKTQ-GLXFQSAKSA-N Cephalosporin C Natural products S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(O)=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- DBTDEFJAFBUGPP-UHFFFAOYSA-N Methanethial Chemical compound S=C DBTDEFJAFBUGPP-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- ITLHXEGAYQFOHJ-UHFFFAOYSA-N [diazo(phenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(=[N+]=[N-])C1=CC=CC=C1 ITLHXEGAYQFOHJ-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- XIURVHNZVLADCM-IUODEOHRSA-N cefalotin Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C(O)=O)C(=O)CC1=CC=CS1 XIURVHNZVLADCM-IUODEOHRSA-N 0.000 description 1
- 229960000603 cefalotin Drugs 0.000 description 1
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 1
- 229960001139 cefazolin Drugs 0.000 description 1
- HOKIDJSKDBPKTQ-GLXFQSAKSA-M cephalosporin C(1-) Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H]([NH3+])C([O-])=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-M 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- NPOMSUOUAZCMBL-UHFFFAOYSA-N dichloromethane;ethoxyethane Chemical compound ClCCl.CCOCC NPOMSUOUAZCMBL-UHFFFAOYSA-N 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000010931 ester hydrolysis Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- CCGKOQOJPYTBIH-UHFFFAOYSA-N ethenone Chemical compound C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- JILPJDVXYVTZDQ-UHFFFAOYSA-N lithium methoxide Chemical compound [Li+].[O-]C JILPJDVXYVTZDQ-UHFFFAOYSA-N 0.000 description 1
- 238000006198 methoxylation reaction Methods 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000006000 trichloroethyl group Chemical group 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/57—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with a further substituent in position 7, e.g. cephamycines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB12819/77A GB1579533A (en) | 1977-03-26 | 1977-03-26 | Cephalosporins and their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS202594B2 true CS202594B2 (en) | 1981-01-30 |
Family
ID=10011720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS781786A CS202594B2 (en) | 1977-03-26 | 1978-03-21 | Process for preparing 7 beta-acylamino-7 alpha-metoxy-3-pyrazinylthiomethyl-3-cephem-4-carboxylates |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4206211A (de) |
| JP (1) | JPS53121790A (de) |
| AT (1) | AT359189B (de) |
| AU (1) | AU514878B2 (de) |
| BE (1) | BE865175A (de) |
| CA (1) | CA1098118A (de) |
| CH (1) | CH637966A5 (de) |
| CS (1) | CS202594B2 (de) |
| DE (1) | DE2812626A1 (de) |
| DK (1) | DK127878A (de) |
| FR (1) | FR2384784A1 (de) |
| GB (1) | GB1579533A (de) |
| GR (1) | GR62540B (de) |
| IE (1) | IE46712B1 (de) |
| IL (1) | IL54203A (de) |
| NL (1) | NL7803282A (de) |
| NO (1) | NO781050L (de) |
| NZ (1) | NZ186619A (de) |
| SE (1) | SE7803388L (de) |
| SU (1) | SU882413A3 (de) |
| YU (1) | YU60978A (de) |
| ZA (1) | ZA781283B (de) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3821207A (en) * | 1971-06-21 | 1974-06-28 | Smithkline Corp | 7-heterocyclic substituted cephalosporins |
| BE787635A (fr) * | 1971-08-20 | 1973-02-19 | Takeda Chemical Industries Ltd | Cephalosporines |
| US3984403A (en) * | 1972-06-30 | 1976-10-05 | Takeda Chemical Industries, Ltd. | Arginine and lysine salts of acid cephalosporins |
| GB1449420A (en) * | 1973-11-26 | 1976-09-15 | Sankyo Co | 7alpha-methoxycephalosporing derivatives |
| US4059578A (en) * | 1974-09-09 | 1977-11-22 | Smithkline Corporation | 7-Substituted mercaptoacetamido cephamycins |
| DK154939C (da) * | 1974-12-19 | 1989-06-12 | Takeda Chemical Industries Ltd | Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf |
| DE2539214C2 (de) * | 1975-09-03 | 1984-03-29 | E.R. Squibb & Sons, Inc., 08540 Princeton, N.J. | 7-Methoxythienyl-ureido-cephalosporin und dieses enthaltendes Arzneimittel |
| US4128723A (en) * | 1977-02-02 | 1978-12-05 | E. R. Squibb & Sons, Inc. | Cyanoalkylureido cephalosporins |
-
1977
- 1977-03-26 GB GB12819/77A patent/GB1579533A/en not_active Expired
-
1978
- 1978-03-03 NZ NZ186619A patent/NZ186619A/xx unknown
- 1978-03-06 CH CH237878A patent/CH637966A5/it not_active IP Right Cessation
- 1978-03-06 ZA ZA00781283A patent/ZA781283B/xx unknown
- 1978-03-06 IL IL54203A patent/IL54203A/xx unknown
- 1978-03-10 US US05/885,126 patent/US4206211A/en not_active Expired - Lifetime
- 1978-03-14 GR GR55706A patent/GR62540B/el unknown
- 1978-03-17 AU AU34244/78A patent/AU514878B2/en not_active Expired
- 1978-03-21 CS CS781786A patent/CS202594B2/cs unknown
- 1978-03-21 IE IE566/78A patent/IE46712B1/en unknown
- 1978-03-21 DK DK127878A patent/DK127878A/da not_active Application Discontinuation
- 1978-03-22 BE BE186166A patent/BE865175A/xx not_active IP Right Cessation
- 1978-03-22 NO NO781050A patent/NO781050L/no unknown
- 1978-03-22 FR FR7808271A patent/FR2384784A1/fr active Granted
- 1978-03-22 DE DE19782812626 patent/DE2812626A1/de not_active Ceased
- 1978-03-23 CA CA299,694A patent/CA1098118A/en not_active Expired
- 1978-03-23 SE SE7803388A patent/SE7803388L/xx unknown
- 1978-03-24 AT AT213078A patent/AT359189B/de not_active IP Right Cessation
- 1978-03-24 SU SU782594352A patent/SU882413A3/ru active
- 1978-03-24 JP JP3399878A patent/JPS53121790A/ja active Pending
- 1978-03-28 NL NL7803282A patent/NL7803282A/xx unknown
- 1978-12-28 YU YU00609/78A patent/YU60978A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE780566L (en) | 1978-09-26 |
| ATA213078A (de) | 1980-03-15 |
| DE2812626A1 (de) | 1978-09-28 |
| NO781050L (no) | 1978-09-27 |
| CA1098118A (en) | 1981-03-24 |
| YU60978A (en) | 1983-01-21 |
| IL54203A0 (en) | 1978-06-15 |
| JPS53121790A (en) | 1978-10-24 |
| GB1579533A (en) | 1980-11-19 |
| AT359189B (de) | 1980-10-27 |
| IE46712B1 (en) | 1983-09-07 |
| DK127878A (da) | 1978-09-27 |
| BE865175A (fr) | 1978-09-22 |
| SE7803388L (sv) | 1978-09-27 |
| ZA781283B (en) | 1979-02-28 |
| GR62540B (en) | 1979-05-04 |
| NL7803282A (en) | 1978-09-28 |
| FR2384784A1 (fr) | 1978-10-20 |
| FR2384784B1 (de) | 1982-05-28 |
| IL54203A (en) | 1981-05-20 |
| CH637966A5 (it) | 1983-08-31 |
| AU514878B2 (en) | 1981-03-05 |
| AU3424478A (en) | 1979-09-20 |
| US4206211A (en) | 1980-06-03 |
| SU882413A3 (ru) | 1981-11-15 |
| NZ186619A (en) | 1979-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS209878B2 (en) | Method of making the new alcyloxime derivatives of the 7-/2-(2-amino-4-thiazolyl)acetamido/cephalosporan acid | |
| CA1109859A (en) | Thiooxime cephalosporin and penicillin derivatives | |
| US5202315A (en) | Cephalosporin compounds | |
| US4356174A (en) | Beta-lactamase inhibiting 2-beta-substituted-2-alpha-methyl-(5R)penam-3-alpha-carboxylic acid 1,1-dioxides and intermediates therefor | |
| US4145540A (en) | 7β-Phosphoramido-7α-methoxycephalosporanic acid derivatives | |
| SE451329B (sv) | 6-beta-jod-substituerade penicillansyror | |
| US4034090A (en) | Cephalosporin derivatives | |
| US3799924A (en) | Ester cleavage process | |
| IE47037B1 (en) | Isopenicillins, processes for their preparation, and compositions containing them | |
| CS214660B2 (en) | Method of preparation of compounds | |
| US3968109A (en) | Production of 2-(thio substituted)cephalosporin sulfoxides and 2-(thio substituted)cephalosporins | |
| CS202594B2 (en) | Process for preparing 7 beta-acylamino-7 alpha-metoxy-3-pyrazinylthiomethyl-3-cephem-4-carboxylates | |
| US3941779A (en) | Method for producing 2-(substituted thio)-3-cephem derivatives | |
| US5605895A (en) | Cephalosporin antibiotics and processes for preparation thereof | |
| US4735938A (en) | 2-aminothiazolyl-containing β-lactam antibiotics | |
| US3991051A (en) | [(Oxyalkyl)thioacetyl]cephalosporin derivatives | |
| US4179502A (en) | 7[2-Hydroxyiminoacetamido]cephalosporins | |
| US3928335A (en) | {8 {8 (Alkylthioc arbonyl)oxy{9 acetyl{9 cephalosporins | |
| US4173703A (en) | Preparation of carbamates | |
| US4003893A (en) | 3-Heterothio[(thioalkyl)thioacetyl]cephalosporanic derivatives | |
| US4148996A (en) | 3,7-Disubstituted cephalosporins | |
| US4661480A (en) | Formamido oxacephems | |
| US4252808A (en) | β-Lactam antibacterial agents, their use in pharmaceutical compositions, the process for their preparation and intermediates for use in that process | |
| CA2003836A1 (en) | Penem derivatives and processes for their preparation | |
| US4171435A (en) | [(Thioalkyl)thioacetyl)]cephalosporin derivatives |